This article discusses communication problems of transsexuals and gives an example of phoniatric and logopedic assessment as well as a possible ‘prototype’ of speech therapy with male-to-female transsexuals.
© 2000 S. Karger AG, Basel
Mw Drs M.D. de Bruin
University Hospital Vrije Universiteit Amsterdam
ENT/Phoniatric Department/2-2k-1, PO Box 7057
NL–1007 MB Amsterdam (The Netherlands)
Tel. +31 20 4440967, Fax +31 20 4440983, E-Mail md.deBruin@azvu.nl
Number of Print Pages : 8
Number of Figures : 0, Number of Tables : 0, Number of References : 14
Folia Phoniatrica et Logopaedica (International Journal of Phoniatrics, Speech Therapy and Communication Pathology)
Founded in 1947 by R. Luchsinger, M. Seeman and J. Tarneaud
Official Organ of the International Association of Logopedics and Phoniatrics (IALP)
Vol. 52, No. 5, Year 2000 (Cover Date: September-October 2000)
Journal Editor: S. Fex, Lund
ISSN: 1021–7762 (print), 1421–9972 (Online)
For additional information: http://www.karger.com/journals/fpl
Article / Publication Details
Published online: 8/14/2000
Issue release date: September–October 2000
Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 0
ISSN: 1021-7762 (Print)
eISSN: 1421-9972 (Online)
For additional information: http://www.karger.com/FPL
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.